Fournier’s Gangrene

Source Category

Causes / Examples

Anorectal Sources (Most Common, 30–50%)

Perianal abscess

Ischiorectal abscess

Anal fissure infection

Rectal perforation

Colorectal cancer

Crohn disease

Urogenital Sources

Urethral stricture,Urethral trauma

Catheter-related infection

Epididymo-orchitis

Prostatic abscess

Urinary tract infection (UTI)

Skin Sources

Folliculitis,Furuncle

Hidradenitis suppurativa

Infected sebaceous cyst

Scrotal trauma

Postoperative Causes

Hemorrhoidectomy

Circumcision,Vasectomy

Urethral surgery,Perineal surgery

Risk Factor

Details / Mechanism

Diabetes Mellitus

Most important risk factor.

Present in 40–70% of cases.

Causes impaired neutrophil function, microvascular disease, and poor wound healing.

Alcoholism

Associated with malnutrition and immune dysfunction, increasing susceptibility to severe infection.

Obesity

Associated with poor tissue oxygenation, impaired wound healing, and increased risk of soft-tissue infections.

Chronic Kidney Disease (CKD)

Commonly associated due to immune dysfunction, frequent healthcare exposure, and impaired host defenses.

Immunosuppression

Examples include:

• Human immunodeficiency virus infection (HIV)

• Chemotherapy

• Chronic corticosteroid therapy

• Solid-organ or hematopoietic transplant recipients

Liver Disease

Associated with impaired immunity, malnutrition, and increased susceptibility to severe infections.

Malignancy

Cancer and its treatments can cause immunosuppression and increase infection risk.

Peripheral Vascular Disease

Poor tissue perfusion promotes ischemia and facilitates rapid spread of infection.

Advanced Age

Associated with reduced immune function and multiple comorbidities.

Smoking

Causes microvascular compromise, impaired wound healing, and increased infection risk.

Organism Group

Common Pathogens in Fournier’s Gangrene

Gram-Negative Bacteria

Escherichia coli (most common isolate)

Klebsiella species

Proteus species

Pseudomonas aeruginosa

Gram-Positive Bacteria

Staphylococcus aureus (including MRSA)

Streptococcus species (especially Group A Streptococcus)

Enterococcus species

Anaerobic Bacteria

Bacteroides species

Clostridium species

Peptostreptococcus species

Stage

Clinical Features

Local Findings (Early Disease)

Swelling

Erythema

Warmth

Tenderness

Commonly Affected Regions

Scrotum

Penis

Perineum

Perianal area

Progressive Disease (Hours to Days)

Skin discoloration

Bullae formation

Dusky or violaceous skin

Skin and soft-tissue necrosis

Advanced Disease

Crepitus – due to gas-producing organisms (not always present)

Foul-smelling wound – characteristic, due to anaerobic infection

Purulent discharge – may occur

Black gangrenous tissue – late sign indicating extensive necrosis

Systemic Features

Fever

Chills/rigors

Tachycardia

Hypotension

Altered sensorium (confusion, delirium, decreased consciousness)

Septic shock

Laboratory Investigation

Typical Findings / Significance

Complete Blood Count (CBC)

Leukocytosis is common, often 15,000–20,000/mm³ or higher.

May also show anemia and thrombocytopenia in severe sepsis.

C-Reactive Protein (CRP)

Usually markedly elevated due to severe inflammation and tissue necrosis.

Serum Lactate

Important prognostic marker.

Elevated lactate suggests severe disease, tissue hypoperfusion, septic shock, and increased mortality risk.

Renal Function Tests

May show Acute Kidney Injury (AKI) with elevated serum creatinine and BUN due to sepsis, dehydration, or multiorgan dysfunction.

Electrolytes

Hyponatremia is common and is associated with severe necrotizing soft-tissue infection.

May also demonstrate other electrolyte abnormalities secondary to sepsis and organ dysfunction.

Coagulation Profile

May reveal coagulopathy and Disseminated Intravascular Coagulation (DIC) in advanced disease.

Imaging Modality

Findings / Role in Fournier’s Gangrene

Ultrasound (USG)

• Scrotal wall thickening
• Subcutaneous gas (hyperechoic foci with dirty shadowing)
• Edema and fluid collections
• Helpful in the Emergency Department (ED) for rapid bedside assessment

CT Scan (Investigation of Choice)

• Fascial thickening
• Subcutaneous gas
• Fluid collections
• Abscess formation
• Fat stranding
• Extent of disease spread into perineum, abdominal wall, retroperitoneum, or thighs
• Most useful imaging modality for diagnosis and surgical planning

MRI

• Most sensitive imaging modality for soft-tissue and fascial involvement
• Excellent delineation of disease extent
• Rarely practical in emergency settings
• Too time-consuming for unstable or septic patients

Antibiotic

Dose

Duration / Notes

Piperacillin–Tazobactam

4.5 g IV every 6 hours(or extended infusion 4.5 g IV over 3–4 h every 8 h)

Continue until adequate source control achieved and patient clinically improving. Total antibiotic duration is typically 10–14 days, but may be longer depending on extent of infection and response. Adjust for renal dysfunction.

Vancomycin

Loading dose: 20–30 mg/kg IV (actual body weight, max usually 2–3 g)

Maintenance: 15–20 mg/kg IV every 8–12 h

Dose guided by AUC/MIC (target AUC 400–600 mg·h/L) or trough monitoring where AUC unavailable. Continue until MRSA is excluded and according to culture results. Adjust for renal function.

Clindamycin

900 mg IV every 8 hours

Usually continued during the acute necrotizing phase for toxin suppression. Commonly maintained for at least the first 48–72 hours and until hemodynamic stabilization/source control, then reassessed according to culture results.

Antibiotic

Dose

Meropenem

1 g IV every 8 hours (2 g IV every 8 h may be used in severe sepsis/shock)

Vancomycin

Loading 20–30 mg/kg IV, then 15–20 mg/kg IV every 8–12 h

Clindamycin

900 mg IV every 8 h

Situation

Recommended Duration

Uncomplicated course with adequate debridement

Usually 10–14 days

Extensive necrosis or persistent infection

2–3 weeks or longer

Bacteremia, osteomyelitis, or deep organ involvement

Individualized; often ≥4–6 weeks depending on source

Stopping antibiotics

Generally when patient is afebrile, hemodynamically stable, no further debridement is needed, and clinical/laboratory improvement is evident